Merck

Built to Serve Pioneers

There’s a new name in CDMO with proven experience. With Millipore® CTDMO Services we simplify bringing life-changing molecules to market, from pre-clinical to commercial.

Millipore® Contract Testing, Development, and Manufacturing Organization (CTDMO) Services

 Modalities where we have focused leadership are mAbs, ADC, HPAPI, VGT, mRNA & LNP formulation


Modalities where we have focused leadership are mAbs, ADC, HPAPI, VV, mRNA & LNP formulation

Our integrated Millipore® CTDMO Services is combining our expertise in development, manufacturing, and contract testing.

Designed to support clients seeking a single partner who can leverage technical leadership, we provide a streamlined experience that covers the entire value chain from pre-clinical to commercial.

We are united with our clients around a single goal, to help patients, by forging partnerships aimed at bringing their pioneering breakthroughs to life.

Our contract testing services are integrated into the modality services to further streamline their development path. Our expertise, speed and agility is what makes the difference for your innovations.

We leverage 30+ years of global success working with drug development, material science and process technology aligned with our supply network to accelerate your program. We are the industry’s experienced choice, built to serve pioneers.


Our CTDMO Services are Focused on the Modalities with the Most Patient Impact

Monoclonal Antibodies
Monoclonal Antibodies

Monoclonal Antibodies (mAbs) have matured to become a core therapeutic modality, with more than 128 mAbs now approved for a wide range of diseases. Our highly experienced experts will help you to optimize, scale, and validate your manufacturing process to get you to late clinical and commercial success.

ADC & Bioconjugation
ADC & Bioconjugation

Antibody-drug conjugates (ADC), known as “magic bullets”, have ignited a new era of targeted cancer therapy. With more than 35 years of experience, we are a leading expert in the conjugation of highly active molecules to monoclonal antibodies for the development and manufacture of ADCs.

High Potent APIs
Highly Potent APIs

Highly potent APIs (HPAPIs) are a powerful component in the treatment of diseases such as cancer. As one of the industry’s largest global manufacturers of HPAPIs, we have over 30 years of experience in the development and production of these complex, multi-step compounds.

Viral Vector
Viral Vector

Viral vectors (VVs) are used to deliver novel genetic material to cells advancing the potential to treat a wide range of diseases. With more than 25+ years of contract manufacturing experience, we have produced over 1,000 batches of virus to support gene therapy development from clinical through commercialization.

mRNA & LNP Formulation
mRNA & LNP Formulation

mRNA technology uses non-viral delivery systems and offers a great deal of versatility. As naked mRNA is unstable, drug delivery systems, such as lipid nanoparticles, are necessary to deliver mRNA to target cells. Our integrated CDMO capabilities include the development and manufacture of custom mRNAs and formulation of lipid nanoparticles (LNP). 

Learn more about our small molecule services supporting Complex API and Activated PEGs


Woman looking at cell phone

Why Contract Testing Services with your CDMO Offering Matters

Our clients manage multiple partners, supply chain needs, and complex priorities along the drug development life cycle. Our CTDMO services provide a unified and simplified experience covering the entire value chain making us your one trusted partner.


We are the Industry’s Experienced Choice

Technology Leadership
Technology Leadership

We industrialize science by standardizing manufacturing templates.

We utilize process technology and consumables that are designed to create efficient and effective processes tailored to clients’ needs. 

Global Capacity and Reach
Global Capacity and Reach

We meet clients where they need us. We are a global organization, making significant investments in our talent and capabilities.

Streamlined Supply Chain Management
Streamlined Supply Chain Management

Our approach allows us to simplify complex supply chain needs within our extensive services network, enabling a truly integrated solution for clients.   

Extensive Regulatory Know-How
Extensive Regulatory Know-How

We apply regulatory expertise gained over decades to inform and navigate clients’ pathways to approval. Our global know-how supports quality standards to ensure compliance where it matters.



CTDMO map

The Global Footprint of Our CTDMO Manufacturing Sites

We are a single organization with a global network to deliver CTDMO services across all stages of the molecule value chain.

North America

Scientist at drawing board
Burlington, MA

Biopharma development and manufacturing facility for mAbs with pilot production up to 200L. 

Carlsbad, CA
Carlsbad, CA

Our state-of-the-art Viral and Gene Therapy Manufacturing site provides a complete range of services with over 25 years of experience.

Indianapolis, IN
Indianapolis, IN

Our site for LNP formulation and fill/finish services completes our mRNA value chain.

Madison, WI
Madison, WI

Our API manufacturing site SafeBridge® certified facility. The world’s largest single nanogram containment facility in 2022.

Verona, WI
Verona, WI

Our API manufacturing site SafeBridge® certified facility.

St. Louis, MO
St. Louis, MO

Our ADC & Bioconjugation manufacturing site. We offer more than 35 years of experience as the leading expert in the conjugation of HPAPI to mAbs for ADC manufacture.

Rockville, MD
Rockville, MD

Testing service site including product characterization, cell banking, cell line characterization, viral clearance, and lot release for our integrated CTDMO.

Hamburg, GER
Hamburg, Germany

Our mRNA manufacturing site for our integrated CDMO capabilities includes the development and manufacturing of custom mRNAs.

Martillac, France
Martillac, France

Biopharma development and manufacturing facility for mAbs production with over 25+ years of GMP experience. Including pilot, and GMP capabilities.

Schaffhausen, Switzerland
Schaffhausen, Switzerland

Our site for the manufacturing of lipid nanoparticles. Our synthetic cholesterol product offers high purity, scalability, and consistent quality.

Glasgow, SC
Glasgow, Scotland

Testing service site including product characterization, cell banking, cell line characterization, viral clearance, and lot release for our integrated CTDMO.

Shanghai, China
Shanghai, China

Biopharma development and manufacturing facility for mAbs with pilot and GMP capabilities.

Shanghai, CN
Shanghai, China

One of our viral clearance service facilities for our integrated CTDMO.

Singapore
Singapore

Testing service site including cell line characterization, viral clearance, and lot release for our integrated CTDMO.